您的浏览器禁用了JavaScript(一种计算机语言,用以实现您与网页的交互),请解除该禁用,或者联系我们。 [KOTRA]:2024韩国外商投资指南 - 发现报告

2024韩国外商投资指南

2024-12-29 KOTRA 邵泽
报告封面

MAIN SUMMARY 004Key Changes inthe 2024 ForeignInvestment Guide 008KOTRA's FDI-relatedPublications CONTENTSPROCEDURE 0121. Foreign InvestmentPromotion Policy INCENTIVE Acquisition of Real Estate 0781. Tax Reduction andExemption0942. Foreign InvestmentZones1023. Cash Grant1104. R&D Support1205. Management Suport 1861. Acquisition of RealEstate PRACTICE Appendix 1281. Taxation1462. Customs Clearanceand Introduction ofCapital Goods1543. HR and Labor1684. Intellectual PropertySystem1765. Foreign InvestmentOmbudsmanSystem1806. Dissolution andLiquidation 196[Appendix 1]Businesses Prohibitedfrom Foreign Investment 198[Appendix 2]Businesses Restrictedfrom Foreign Investmentand Criteria for Permission 200[Appendix 3]LocalTaxRate 201[Appendix 4]KOTRA’sOverseasInvestmentHubOffices 202[Appendix 5]ListofDelegatedAgencies 203[Appendix 6]ListofLawFirms[Appendix 7]ListofAccountingandTaxFirms 2024 KEY CHANGESIN THE FOREIGNINVESTMENT GUIDE Main Summary Expansion of national strategic technology and new growth enginesource technology Expansion of the scope of biomedicine sector and detailed technologyand commercialization facilityp.90p.105(Attached Table 7-2 of the Enforcement Decree of the Act on Restriction on Special CasesConcerning Taxation and Table 6-2 of its Enforcement Rules) -6 areas, 54 technologies, 46 facilities for national security -> 7 areas*, 62 technologies, 50 facilities*① Semiconductors, ② Secondary battery, ③ Vaccine, ④ Display, ⑤ Hydrogen, ⑥ Future mobility, ⑦ Biomedicine- Biomedicine sector ➊Discovering new biomedicine candidate substancesand manufacturing technology➋Biosimilar manufacturing and improvement technology➌Clinical pharmacological trial evaluation technology (phase1 clinical trial)➍Therapeutic investigation clinical evaluation technology(phase 2 clinical trial)➎Therapeutic proof clinical evaluation technology (phase3 clinical trial)➏Biomedicine ingredient and material manufacturingtechnology➐Biomedicine parts and equipment design and manufacturingtechnology➑Biomedicine new drug non-clinical trial technology Technology 8 technologiesNational strategic technology (Attached table 7-2 of theEnforcement Decree of the Acton Restriction on Special CasesConcerning Taxation) ➊Discovering new biomedicine candidate substances andmanufacturing technology Commercializationfacility4 facilitiesCommercialization facility ➋Biosimilar manufacturing and improvement technology ➌Clinical pharmacological trial evaluation technology (phase1 clinical trial) (Attached table 6-2 of the Enforcement Rule of the Act on Restriction on Special Cases Concerning Taxation) ➍Therapeutic investigation clinical evaluation technology(phase 2 clinical trial) Addition of new growth and source technologyp.81(Attached table 6-2 of the Enforcement Rule of the Act on Restriction on Special CasesConcerning Taxation) •262 technologies in 13 areas*→ Addition of essential technology related to the supply chain such as core technologyfor energy efficiency and refinement and smelting of core minerals Industrial Sites Establishment of high-tech investment zone Newly created the "Advanced Investment District" to facilitate investment due to thegrowing importance of nurturing advanced industries following the restructuring ofindustries in the aftermath of the 4th industrial revolution and COVID-19. High-tech investment ① High technology and products involving high technology under the Industrial Development Act② Investment to operate a business accompanying new growth driver industry technologyunder the Restriction of Special Taxation Act Designation Area favored as destinationof large-scale high-techinvestment Existing planned sites (industrial complexes, FIZs, FEZs) * Designation process: (Application) Head of the central administrative agency or governor ofcity or province → (Screening) High-tech investment zone committee → (Designation & publicannouncement) Minister of Trade, Industry and Energy Incentives ①Taxation support, reduction of charges*, subsidy priority*** 50% reduction of expenses incurred in creating forest replacement resources for semi-preserved mountainous districts, 50% reduction of expenses incurred for agricultural land protectionoutside of agricultural promotion zones, 100% reduction of traffic-incurred costs (manufacturingfactory under the Industrial Cluster Development and Factory Establishment Act)** 2%p bonus to the calculation ratio of regional investment subsidies and facility subsidies② Long-term rental and fee reduction of state-owned or public assets③Minimum site restriction area, credit guarantee, etc. Designation status New designation of9 advanced investmentzones (Sep. 23) * Complex-type (1):Asan TangjeongIndividual-type (8):Busan 1, Ulsan 1, Gyeonggi 1, Chungnam 2,Jeonbuk 3 Chungnam Jeonbuk •Asan Tangjeong•Global Wafers Co., Ltd.•NEXCON Technology Co., Ltd. •HR E&I Co., Ltd.•Doosan Co., Ltd.•ENEREVER Battery SolutionCo.